Analysis of subgroups revealed that treatment was more effective in patients with alcohol-related cirrhosis (p = 0.01) and in groups of patients with nonalcoholic cirrhosis, whereas it was ...
The flavonoid silymarin and one of its structural components, silibinin, are substances with documented hepatoprotective properties. Their mechanisms of action are still poorly understood.